Results and Discussion CALLA was purified from kidney extracts by immunoaffinity chromatography using mAb 44C10, produced by immunisation with the CALLA-positive leukemic cell line HOON (8) , and reactive with the same epitope as other widely used anti-CALLA mAb (2) (3) (4) (5) (6) (7) (8) . The M, of the antigens immunoprecipitated with mAb 44C10 were estimated at 9.4 x 104 (kidney) and 105 (NOON) ; after Endo F digestion, both polypeptides had an apparent M, of 8 x 104. The CALLA glycoprotein was purified on average 200-300-fold relative to the crude kidney extract . From a whole kidney cortex, 6 mg of protein representing 40-50% ofthe CALLA antigenic activity were recovered after immunoaffinity chromatography. The protein, purified an additional 12-fold by electrophoretic elution from polyacrylamide gels, migrated as a single band; Mr, 9.4 x 104. The sequences of CNBr peptides 1 and 2 ( Fig. 1) were determined for two independent preparations, with identical results .
A cDNA clone was isolated from a human kidney library using a mixed oligonucleotide probe corresponding to the sequence ofpeptide 2 (MNPEKK). This clone (N3.4 kb) also hybridized with a mixed oligonucleotide probe derived from a partial sequence of peptide 1 (MVIGHE) . We determined the nucleotide sequence of two Eco RI fragments (0.7 and 1.6 kb) of this cDNA, and compared these sequences with all entries in the GenBank nucleotide sequence database . Both fragments showed a high degree ofsimilarity (86% and 91%, respectively) with the sequence of a cDNA coding for the rat NEP (28) . The 0.7-kb fragment corresponds to the 5' untranslated and NH2-terminal coding regions, while the 1 .6-kb fragment covers two thirds of the coding region.
Examination of more recent entries into the data banks revealed that both rabbit (29) and human (20) NEP had also been cloned and sequenced . Compared with the human NEP cDNA, the CALLA cDNA sequence was missing a 60-bp Eco RI fragment between the two sequenced regions, and 39 bases of coding sequence before the termination codon . Translation of the CALLA cDNA into an amino acid sequence confirmed that the protein is identical to human NEP and 95% identical to rat or rabbit NEP (20, 21) . Peptide 2, not found in the sequenced portion of the CALLA cDNA, is identical to residues 741-746 of human and rabbit NEP.
The Tend of the CALLA cDNA clone extends 143 nucleotides further than the human NEP cDNA clone and contains a stop codon located 6 by 5' of the first AUG codon, as seen for rat and rabbit NEP (28, 29 are conserved between species: the transmembrane domain, the stop transfer sequence, the positions of the cysteine residues, the potential glycosylation sites (five out of six), and the pentapeptide consensus sequence (H-E-[I, L, M]-x-H) of zincbinding metalloproteases (30, and Bouvier, J., A. Bairoch, and C. V. Jongeneel, submitted for publication; see Fig. 1 ).
We probed Northern blots of RNA extracted from two leukemic cell lines, HOON and NALM-6, and from human and mouse fibroblasts, with the 1.6-kb CALLA cDNA fragment (Fig. 2) . The amounts ofCALLA mRNA correlated with the amounts of CALLA detected at the cell surface by flow cytometry. The probe hybridized to two RNA species of 3.8 and 6.6 kb. These sizes correspond to those described for the rat NEP mRNAs (28) . In RNA extracted from NALM-6 cells, we could detect one additional minor species of 5.0 kb . The same three mRNA species were observed in human kidney, at a higher abundance than in NALM-6; however, they were absent from RNA extracted from the T leukemia line Jurkat (data not shown) . No CALLA mRNA could be detected in mouse fibroblasts (Fig. 2) .
CALLA is a very useful diagnostic marker of common (pre-B) ALL, being absent from normal lymphocytes and monocytes; it is however present on some stem cells in fetal liver, bone marrow and thymus (12, 13), on some lymphomas (2, 3) and on melanoma and glioma cell lines (17, 18) . It is, thus, neither leukemia specific nor confined to a single tissue but is expressed on normal and neoplastic cells of diverse origins. The presence of NEP on malignant cells or tissue has not been documented . Both CALLA and NEP have been independently observed on epithelial cells of kidney and gut (9-11, 21-23, 31), on neutrophils (14-16, 19, 24) , and on cultured fibroblasts (15, 32) . Within the kidney, where they are particularly abundant, both CALLA and NEP are found on the brush border of proximal tubules and on glomerular epithelium (9-11, 21-23, 31) . CALLA antigens from leukemic cells (4) (5) (6) (7) (8) 16) , kidney (9, 11) , melanoma (17) , glioma (18) , granulocytes (14, 15, 19) , or fibroblasts (15) , and NEP from kidney (21) (22) (23) (28) (29) , brain (28), or fibroblasts Northern blot of human leukemic cells and fibroblasts probed with CALLA cDNA . RNA samples (20 pg) prepared from the HOON (H) and NALM-6 (N) pre-B ALL cell lines and from human (HF) or mouse (MF) fibroblasts were fractionated on a denaturing agarose gel. After transfer to a nylon membrane, the RNAs were probed with "P-labeled 1.6-kb CALLA cDNA fragment .
We thank J. NEP has been studied extensively in brain as an inactivator ofenkephalins ; inhibitors of the enzyme have analgesic properties (28) . Although there are no reports of the presence of CALLA in brain, it has been described on several glioma cell lines (18) .
Kidney and neutrophil NEP can cleave the chemotactic peptide, fmLF, and polyclonal antibody to human kidney NEP can inhibit the hydrolysis of the tripeptide by a neutrophil membrane fraction enriched in NEP (24) . It is ofinterest that mAb to CALLA can inhibit 20% of fMLF-induced neutrophil chemotaxis (19) . Since cleavage of chemotactic peptides is required for neutrophil degranulation and chemotaxis, CALLA (NEP) might be important in neutrophil function (19, 24) .
Our observation that the structure of CALLA corresponds to that of an enzyme able to hydrolyze a variety of polypeptide hormones opens new avenues for testing the function of this molecule in leukemic cells and its potential role in the process of malignancy. In this context, it is of interest that transin, a zinc metalloprotease belonging to the same superfamily as NEP, can be induced by oncogenes and is expressed more abundantly in malignant than in benign tumors (33).
Summary
We purified CALLA from human kidney and isolated a cDNA clone reactive with two oligonucleotide probes corresponding to two distinct peptides. The amino acid sequence translated from the CALLA cDNA revealed 100% identity with that of human neutral endopeptidase (NEP, enkephalinase) . The distributions of CALLA antigen and NEP in normal tissues are similar.
Note added in proof: The sequence of the CALLA cDNA has been completed and is identical to that shown in Fig. 1 for human NEP. While this manuscript was in press, the sequence of a CALLA cDNA isolated from the NALM-6 leukemic cell line has been reported (34) and is identical to our sequence .
